Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ubiquinone and Antioxidants in NPDR
NCT02062034Phase 2Completed
- Sponsor
- Universidad de Guadalajara
- Start
- Feb 2011
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of coenzyme q10 (3 arms), sponsored by Universidad de Guadalajara. Primary endpoint: Oxidative Stress markers at 24 weeks. Started Feb 2011; status: completed.
02
Drugs
coenzyme q10
Beyond the preview
Go deeper on NCT02062034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02062034.